Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
102.51
-0.29 (-0.28%)
Feb 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 102.48 - 103.33
52 week 90.75 - 109.49
Open 103.04
Vol / Avg. 8.50M/10.48M
Mkt cap 285.03B
P/E 17.98
Div/yield 0.70/2.73
EPS 5.70
Shares 2.78B
Beta 0.55
Inst. own 67%
Apr 13, 2015
Q1 2015 Johnson & Johnson Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 20, 2015
Q4 2014 Johnson & Johnson Earnings Release
Jan 20, 2015
Q4 2014 Johnson & Johnson Earnings Call - Webcast
Jan 12, 2015
Johnson & Johnson at JPMorgan Healthcare Conference (Q&A Session)
Jan 12, 2015
Johnson & Johnson at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 13.81% 21.96%
Operating margin 14.81% 27.66%
EBITD margin - 35.39%
Return on average assets 7.68% 12.38%
Return on average equity 13.82% 22.70%
Employees 126,500 -
CDP Score - 99 B

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies across the world. The Company�s primary focus has been on products related to human health and well-being. Johnson & Johnson's subsidiaries operate 144 manufacturing facilities occupying approximately 21.7 million square feet of floor space. The Company operates three business segments: Consumer, which offers a range of consumer products to general public; Pharmaceutical, which offers health related products through retailers, wholesalers and health care professionals for prescription use, and Medical Devices and Diagnostics, which offers a range of products to physicians, nurses, hospitals, and clinics.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 56
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 55
Bio & Compensation  - Reuters
Paulus Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 52
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 55
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 51
Bio & Compensation  - Reuters
Ernesto Quinteros Chief Design Officer
Age: 51
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 61
Bio & Compensation  - Reuters
D. Scott Davis Director
Age: 62
Bio & Compensation  - Reuters
Mary Sue Sue Coleman Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters